Assessment of serum calcium levels and its outcome among transfusion dependent beta thalassemia major patients on chelation therapy

Authors

  • Kaynat Ali Combined Military Hospital, Bahawalpur Pakistan
  • Sohail Shahzad Combined Military Hospital, Bahawalpur Pakistan
  • Farooq Ahmed Combined Military Hospital, Bahawalpur Pakistan
  • Naila Hamid Combined Military Hospital, Bahawalpur Pakistan
  • Hina Basharat Combined Military Hopsital, Bahawalpur Pakistan
  • Huzaifa Usman Combined Military Hospital, Bahawalpur Pakistan

DOI:

https://doi.org/10.55629/pakjpathol.v36i3.944

Abstract

Objective: To analyze the serum calcium levels and its outcome among blood transfusion dependent β-Thalassemia major patients on chelation therapy.

Material and Methods: cross-sectional study design was employed to conduct the study. A total of 250 children diagnosed (5-12 years old) with beta thalassemia major undergoing regular blood transfusions, presented to the pediatric ward of CMH Bahawalpur between June 2024 and June 2025 were included in the study. The approval of the ethical review board and written informed consent of the respondents and their guardians were obtained for conducting the study. The patients with their guardians were then approached for data collection. Laboratory analysis of the fresh blood samples of the patients, under aseptic measures, was conducted for serum calcium levels with the documentation of results.

Results: This study found a significant association between hypocalcemia and the occurrence of clinical symptoms in transfusion dependent thalassemia patients. Carpopedal spasm (4.5%), numbness (13.4%), bone pain (46.3%), and fractures (19.4%) were observed exclusively in patients with hypocalcemia, while none of these symptoms were present in those with normocalcemia. The associations were statistically significant, with p-values < 0.05 for all variables except seizures, which were not reported in either group.

Conclusion: Hypocalcemia was significantly associated with carpopedal spasm, numbness, bone pain, and fractures in transfusion-dependent thalassemia patients, with females showing a higher burden of complications. Regular calcium monitoring is essential to reduce morbidity in this population.

Keywords: Beta thalassemia, Blood transfusion, Chelation therapy, Hypocalcemia.

References

Langer AL, Esrick EB. β-Thalassemia: Evolving treatment options beyond transfusion and iron chelation. Hematol. 2021; 2021(1): 600-6. DOI: https://doi.org/10.1182/hematology.2021000313

Khaliq S. Thalassemia in Pakistan. Hemoglobin. 2022; 46(1): 12-4. DOI: https://doi.org/10.1080/03630269.2022.2059670

Lulla HS, Lakhani SL, Patil SD, Chaudhry H, Warthe VM. Blood transfusion complications prevalence parametric causes for stress of disease and management of transfusion dependent thalassemia: A narrative review. World J Pharm Res. 2020; 9 (7): 1192-220. Available from: https://www.wisdomlib.org/ uploads/journals/wjpr/volume-9,-july-issue-7_1472 3.pdf

Majumder A, Basu S. Hypoparathyroidism in a case of transfusion dependent thalassemia. Journal of the ASEAN Fed Endocrine Soc. 2020; 35(1): 129-32. DOI: https://doi.org/10.15605/jafes.035.01.23

Strain JJ, Cashman KD. Minerals and trace elements. Introduction to human nutrition. 2009; 24: 188.

DOI: https://doi.org/10.1002/9781394322428.ch11

Moustafa SR, Kadhem Al-Hakeim H, Alhillawi ZH, Maes M. In transfusion-dependent thalassemia children, increased iron overload is associated with lower serum alpha-klotho, which is strongly associated with lower total and ionized calcium concentrations. Curr Mol Med. 2023; 23(5): 442-52. DOI: https://doi.org/10.2174/15665240226662 20607163232

Theppornpitak K, Trakarnsanga B, Lauhasurayotin S, Poparn H, Chiengthong K, Sosothikul D, et al. A study to assess and improve adherence to iron chelation therapy in transfusion-dependent thalassemia patients. Hemoglobin. 2021; 45(3): 171-4. DOI: https://doi.org/10. 1080/03630269.202 1.1934010

Orhan Ö, Demir H, Talay MN, Özgün N, Özbek MN. Evaluation of children and adolescents with thalassemia major in terms of osteoporosis: A single-centre experience. J Clin Med. 2025; 14(5): 1579. DOI: https://doi.org/10.3390/jcm14051579

Sastry UM, Ray S, Chandra J, Sharma S. Prevalence and correlates of hypocalcemia in transfusion dependent thalassemia. Pediatr Hematol Oncol J. 2020; 5(3): 83–87. DOI: https://doi.org/10.1016/j.phoj.2020.05.001

Catalano A, Chilà D, Bellone F, et al. Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? J Clin Transl Endocrinol. 2018; 13: 9-13. DOI: https://doi.org/10.1016/j.jcte.2018.05.004

Sultan S, Irfan SM, Ahmed SI. Biochemical Markers of bone turnover in patients with β‐thalassemia major: A single center study from southern Pakistan. Adv Hematol. 2016(1): 5437609. DOI: https://doi.org/10.1155/2016/5437609

Shah S. Assessment of serum calcium and phosphorus levels among transfusion-dependent beta thalassemia major patients on chelation therapy. J Postgrad Med Inst. 2015; 29(3): 168-71. Available from: https://jpmi.org.pk/index.php/ jpmi/article/view/1732

Mirhosseini NZ, Shahar S, Ghayour-Mobarhan M, Banihashem A, Kamaruddin NA, Hatef MR, et al. Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents. J Bone Mineral Metab. 2013; 31(4): 468-76. DOI: https://doi.org/10.1007/s00774-013-0433-1

Bou-Fakhredin R, Motta I, Cappellini, MD, Taher AT. Clinical complications and their management. Hematol Oncol Clin N Am. 2023; 37: 365–78. DOI: https://doi.org/10.1016/j.hoc.2017.11.005

Galanello R, Origa R. Beta-thalassemias. Orphanet J Rare Dis. 2010; 15(1): 69. DOI: https://doi.org/10.1186/1750-1172-5-11

De Virgillis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F, et al. Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr. 1988; 113(4): 661-9. DOI: https://doi.org/10.1016/s0022-3476(88)80375-5

Downloads

Published

30-09-2025

How to Cite

1.
Ali K, Shahzad S, Ahmed F, Hamid N, Basharat H, Usman H. Assessment of serum calcium levels and its outcome among transfusion dependent beta thalassemia major patients on chelation therapy. Pak J Pathol [Internet]. 2025 Sep. 30 [cited 2026 Nov. 17];36(3):240-4. Available from: https://pakjpath.com/index.php/Pak-J-Pathol/article/view/944